Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kilgore

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 26, 2007
Performance of a no-pretreatment tacrolimus assay on the Dade Behring Dimension RxL clinical chemistry analyzerMegan A Griffey, Karl G Hock, Daniel C Kilgore, et al.
Gynecologic Oncology|June 1, 1995
T2/3 vulva cancer: a case-control study of triple incision versus en bloc radical vulvectomy and inguinal lymphadenectomyB S Siller, R D Alvarez, W D Conner, et al.
Journal of Lower Genital Tract Disease|May 8, 2015
Histopathological variables predicting high-grade squamous intraepithelial lesions after large-loop excision of the transformation zoneM N Barnes, M W Robertson, R W Naumann, et al.
Gynecologic Oncology|February 1, 1993
The validity and significance of substages of advanced ovarian cancerE E Partridge, B C Gunter, M S Gelder, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 21, 2007
Outcomes for patients with fallopian tube carcinoma managed with adjuvant chemotherapy following primary surgery: a retrospective university experienceC A Leath, T M Numnum, J M Straughn, et al.
Gynecologic Oncology|December 27, 2008
The safety and efficacy of day 1 versus day 2 administration of pegfilgrastim in patients receiving myelosuppressive chemotherapy for gynecologic malignanciesJenny M Whitworth, Kellie S Matthews, Kimberly A Shipman, et al.
Vaccines|November 27, 2021
Pharmacists' Perceived Barriers to Human Papillomavirus (HPV) Vaccination: A Systematic Literature ReviewOluwafemifola Oyedeji, Jill M Maples, Samantha Gregory, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 18, 2011
Assessment of risk factors for 30-day hospital readmission after surgical cytoreduction in epithelial ovarian carcinomaJanelle M Fauci, Kellie E Schneider, Peter J Frederick, et al.
Gynecologic Oncology|December 17, 2003
Complications of indwelling venous access devices in patients with gynecologic malignanciesJacob M Estes, Rodney Rocconi, J Michael Straughn, et al.
Gynecologic Oncology|June 11, 2011
Prognostic significance of the relative dose intensity of chemotherapy in primary treatment of epithelial ovarian cancerJanelle M Fauci, Jenny M Whitworth, Kellie E Schneider, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 26, 2007
Performance of a no-pretreatment tacrolimus assay on the Dade Behring Dimension RxL clinical chemistry analyzerMegan A Griffey, Karl G Hock, Daniel C Kilgore, et al.
Gynecologic Oncology|June 1, 1995
T2/3 vulva cancer: a case-control study of triple incision versus en bloc radical vulvectomy and inguinal lymphadenectomyB S Siller, R D Alvarez, W D Conner, et al.
Journal of Lower Genital Tract Disease|May 8, 2015
Histopathological variables predicting high-grade squamous intraepithelial lesions after large-loop excision of the transformation zoneM N Barnes, M W Robertson, R W Naumann, et al.
Gynecologic Oncology|February 1, 1993
The validity and significance of substages of advanced ovarian cancerE E Partridge, B C Gunter, M S Gelder, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 21, 2007
Outcomes for patients with fallopian tube carcinoma managed with adjuvant chemotherapy following primary surgery: a retrospective university experienceC A Leath, T M Numnum, J M Straughn, et al.
Gynecologic Oncology|December 27, 2008
The safety and efficacy of day 1 versus day 2 administration of pegfilgrastim in patients receiving myelosuppressive chemotherapy for gynecologic malignanciesJenny M Whitworth, Kellie S Matthews, Kimberly A Shipman, et al.
Vaccines|November 27, 2021
Pharmacists' Perceived Barriers to Human Papillomavirus (HPV) Vaccination: A Systematic Literature ReviewOluwafemifola Oyedeji, Jill M Maples, Samantha Gregory, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 18, 2011
Assessment of risk factors for 30-day hospital readmission after surgical cytoreduction in epithelial ovarian carcinomaJanelle M Fauci, Kellie E Schneider, Peter J Frederick, et al.
Gynecologic Oncology|December 17, 2003
Complications of indwelling venous access devices in patients with gynecologic malignanciesJacob M Estes, Rodney Rocconi, J Michael Straughn, et al.
Gynecologic Oncology|June 11, 2011
Prognostic significance of the relative dose intensity of chemotherapy in primary treatment of epithelial ovarian cancerJanelle M Fauci, Jenny M Whitworth, Kellie E Schneider, et al.
Pageof 7